UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 210

Sortiert nach

Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients

Clinical infectious diseases, 2009-08, Vol.49 (4), p.507-514

2009

Link zum Volltext

Verfügbarkeit prüfen

Hospital Transfers Across US Regions to Address the “Space” Shortage in a Pandemic: A Public Good

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e4111-e4112

Anesi, George L

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase–Producing Enterobacterales

Clinical infectious diseases, 2021-06, Vol.72 (11), p.1871-1878

2021

Link zum Volltext

Verfügbarkeit prüfen

Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy

Clinical infectious diseases, 2007-02, Vol.44 (3), p.357-363

2007

Link zum Volltext

Verfügbarkeit prüfen

Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?

Clinical infectious diseases, 2014-09, Vol.59 (5), p.666-675

2014

Link zum Volltext

Verfügbarkeit prüfen

Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis

Clinical infectious diseases, 2010-06, Vol.50 (12), p.1568-1574

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics-Pharmacodynamics of Antimicrobial Therapy: It's Not Just for Mice Anymore

Clinical infectious diseases, 2007-01, Vol.44 (1), p.79-86

2007

Link zum Volltext

Verfügbarkeit prüfen

Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally

Clinical infectious diseases, 2007-09, Vol.45 (6), p.753-760

2007

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic-Pharmacodynamic Considerations in the Design of Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia Studies: Look before You Leap

Clinical infectious diseases, 2010-08, Vol.51 (Supplement-1), p.S103-S110

2010

Link zum Volltext

Verfügbarkeit prüfen

Vancomycin: We Can't Get There From Here

Clinical infectious diseases, 2011-04, Vol.52 (8), p.969-974

2011

Link zum Volltext

Verfügbarkeit prüfen

Drug Transporter and Metabolizing Enzyme Gene Variants and Nonnucleoside Reverse-Transcriptase Inhibitor Hepatotoxicity

Clinical infectious diseases, 2006-09, Vol.43 (6), p.779-782

2006

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Activity of Oritavancin in Animal Infection Models and Rationale for a New Dosing Regimen in Humans

Clinical infectious diseases, 2012-04, Vol.54 (suppl 3), p.S220-S228

2012

Link zum Volltext

Verfügbarkeit prüfen

The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study

Clinical infectious diseases, 2018-11, Vol.67 (12), p.1815-1823

2018

Link zum Volltext

Verfügbarkeit prüfen

Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms

Clinical infectious diseases, 2020-12, Vol.71 (10), p.2599-2607

2020

Link zum Volltext

Verfügbarkeit prüfen

Two Doses of a Lipid Formulation of Amphotericin B for the Treatment of Mediterranean Visceral Leishmaniasis

Clinical infectious diseases, 2003-03, Vol.36 (5), p.560-566

2003

Link zum Volltext

Verfügbarkeit prüfen

In Memoriam: John P. Quinn, MD

Clinical infectious diseases, 2014-03, Vol.58 (5), p.748-750

2014

Link zum Volltext

Verfügbarkeit prüfen

Reply to Donovan et al

Clinical infectious diseases, 2010-10, Vol.51 (8), p.989-990

2010

Link zum Volltext

Verfügbarkeit prüfen

Nosocomial Sinusitis in Patients in the Medical Intensive Care Unit: A Prospective Epidemiological Study

Clinical infectious diseases, 1998-09, Vol.27 (3), p.463-470

1998

Link zum Volltext

Verfügbarkeit prüfen

Guillain-Barré Syndrome Associated with Immune Reconstitution

Clinical infectious diseases, 2003-05, Vol.36 (9), p.e111-e114

2003

Link zum Volltext

Verfügbarkeit prüfen

Mycobacterium neoaurum—An Unusual Cause of Infection of Vascular Catheters: Case Report and Review

Clinical infectious diseases, 1999-03, Vol.28 (3), p.682-683

1999

Link zum Volltext

Verfügbarkeit prüfen

Infection in the Intensive Care Unit: β-Lactamase-Mediated Resistance Among Enterobacteriaceae and Optimal Antimicrobial Dosing

Clinical infectious diseases, 1998-08, Vol.27 (Supplement-1), p.S111-S116

DRUSANO, G. L

1998

Link zum Volltext

Verfügbarkeit prüfen

Nocardiosis in 30 Patients with Advanced Human Immunodeficiency Virus Infection: Clinical Features and Outcome

Clinical infectious diseases, 1994-03, Vol.18 (3), p.348-353

1994

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Activity of Oritavancin in Animal Infection Models and Rationale for a New Dosing Regimen in Humans: Oritavancin for the Treatment of Serious Gram-Positive Infections

Clinical infectious diseases, 2012, Vol.54

2012

Link zum Volltext

Verfügbarkeit prüfen

Penicillin G–Resistant Viridans Group Streptococcal Endocarditis and Interpretation of the American Heart Association's Guidelines for the Treatment of Infective Endocarditis

Clinical infectious diseases, 2008-04, Vol.46 (7), p.1064-1066

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 210

Suche als RSS-Feed

Aktive Filter

KollektionOxford journals

Zeitschrift / SerieClinical Infectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(210)

Publikationsform

Artikel
(210)

Sprache

Englisch
(210)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

Infectious Diseases
(177)
Microbiology
(168)
Immunology
(167)
Life Sciences & Biomedicine
(166)
Science & Technology
(166)
Humans
(156)
Biological And Medical Sciences
(99)
Medical Sciences
(97)
Male
(75)
Female
(72)
Adult
(68)
Infections
(68)
Middle Aged
(47)
Pharmacology. Drug Treatments
(39)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(35)
Child
(31)
Aged
(29)
Hiv
(29)
Antibiotics
(28)
Bacterial Diseases
(27)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Oxford Journals
(210)
Oxford Journals 2020 Medicine
(210)
EZB Electronic Journals Library
(210)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(210)
NUS Single-Journal Subscriptions
(210)
JSTOR
(189)
MEDLINE
(158)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clin Infect Dis
(2)
Clin. Infect. Dis
(2)
Cli Infect Dis
(1)
Clinical Infectious Diseases. Dec 1996
(1)

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients

Hospital Transfers Across US Regions to Address the “Space” Shortage in a Pandemic: A Public Good

Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase–Producing Enterobacterales

Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy

Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?

Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis

Pharmacokinetics-Pharmacodynamics of Antimicrobial Therapy: It's Not Just for Mice Anymore

Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally

Pharmacokinetic-Pharmacodynamic Considerations in the Design of Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia Studies: Look before You Leap

Vancomycin: We Can't Get There From Here

Drug Transporter and Metabolizing Enzyme Gene Variants and Nonnucleoside Reverse-Transcriptase Inhibitor Hepatotoxicity

In Vivo Activity of Oritavancin in Animal Infection Models and Rationale for a New Dosing Regimen in Humans

The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study

Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms

Two Doses of a Lipid Formulation of Amphotericin B for the Treatment of Mediterranean Visceral Leishmaniasis

In Memoriam: John P. Quinn, MD

Reply to Donovan et al

Nosocomial Sinusitis in Patients in the Medical Intensive Care Unit: A Prospective Epidemiological Study

Guillain-Barré Syndrome Associated with Immune Reconstitution

FDA, CDC, and NIH Co-sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea

Mycobacterium neoaurum—An Unusual Cause of Infection of Vascular Catheters: Case Report and Review

Infection in the Intensive Care Unit: β-Lactamase-Mediated Resistance Among Enterobacteriaceae and Optimal Antimicrobial Dosing

Nocardiosis in 30 Patients with Advanced Human Immunodeficiency Virus Infection: Clinical Features and Outcome

In Vivo Activity of Oritavancin in Animal Infection Models and Rationale for a New Dosing Regimen in Humans: Oritavancin for the Treatment of Serious Gram-Positive Infections

Penicillin G–Resistant Viridans Group Streptococcal Endocarditis and Interpretation of the American Heart Association's Guidelines for the Treatment of Infective Endocarditis

Aktive Filter

Suchergebnisse filtern